For the analysis of Rosuvastatin calcium, a specific and uncomplicated HPLC method was devised and validated. Rosuvastatin calcium belongs to the statin family, which is a reductase inhibitor for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA). The medication is used to treat hypertension and ischemic coronary artery disease. It is also used to treat dyslipidemia and aid in the reduction of "bad cholesterol" levels. The technique was carried out on a C18 Column (250 4.6mm 1.d; 5) in isocratic mode with the mobile phase acetonitrile and water in the ratio 75:25 v/v. The wavelength is 242 nm,...
For the analysis of Rosuvastatin calcium, a specific and uncomplicated HPLC method was devised and validated. Rosuvastatin calcium belongs to the stat...
For the analysis of Rosuvastatin calcium, a specific and uncomplicated HPLC method was devised and validated. Rosuvastatin calcium belongs to the statin family, which is a reductase inhibitor for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA). The medication is used to treat hypertension and ischemic coronary artery disease. It is also used to treat dyslipidemia and aid in the reduction of "bad cholesterol" levels. The technique was carried out on a C18 Column (250 4.6mm 1.d; 5) in isocratic mode with the mobile phase acetonitrile and water in the ratio 75:25 v/v. The wavelength is 242 nm,...
For the analysis of Rosuvastatin calcium, a specific and uncomplicated HPLC method was devised and validated. Rosuvastatin calcium belongs to the stat...
In the current scenario, the Gewald synthesis mechanism was used to synthesize a series of 11 newly designed thiophene analogs (D1-D11) derivatives using (Scheme-1, D1-D11). FTIR, 1H-NMR are used for the characterization of the newly synthesized analogs. After structural characterization, these derivatives are then screened for their in vitro biological evaluation. The biological evaluation of designed thiophene analogs was performed to test their antibacterial, antifungal and antioxidant action. Among all the designed and synthesized analogs, compounds D11 and D6 exhibit strong antibacterial...
In the current scenario, the Gewald synthesis mechanism was used to synthesize a series of 11 newly designed thiophene analogs (D1-D11) derivatives us...
Im vorliegenden Szenario wurde der Gewald-Synthesemechanismus verwendet, um eine Reihe von 11 neu entwickelten Thiophen-Analoga (D1-D11)-Derivaten unter Verwendung von (Schema 1, D1-D11) zu synthetisieren. FTIR und 1H-NMR werden zur Charakterisierung der neu synthetisierten Analoga verwendet. Nach der strukturellen Charakterisierung werden diese Derivate dann für ihre biologische Bewertung in vitro gescreent. Die biologische Bewertung der entwickelten Thiophen-Analoga wurde durchgeführt, um ihre antibakterielle, antimykotische und antioxidative Wirkung zu testen. Von allen entwickelten und...
Im vorliegenden Szenario wurde der Gewald-Synthesemechanismus verwendet, um eine Reihe von 11 neu entwickelten Thiophen-Analoga (D1-D11)-Derivaten unt...
Français Dans le scénario actuel, le mécanisme de synthèse de Gewald a été utilisé pour synthétiser une série de 11 nouveaux dérivés d'analogues de thiophène (D1-D11) en utilisant (Schéma-1, D1-D11). FTIR, 1H-RMN sont utilisés pour la caractérisation des analogues nouvellement synthétisés. Après caractérisation structurale, ces dérivés sont ensuite criblés pour leur évaluation biologique in vitro. L'évaluation biologique des analogues de thiophène conçus a été réalisée pour tester leur action antibactérienne, antifongique et antioxydante. Parmi tous les...
Français Dans le scénario actuel, le mécanisme de synthèse de Gewald a été utilisé pour synthétiser une série de 11 nouveaux dérivés d'anal...